Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 631 AL 645

Once upon a time, the Amyloid Cascade Hypothesis

Granzotto A, Sensi SL.

Ageing Res Rev. 2024 Jan;93:102161. doi: 10.1016/j.arr.2023.102161. Epub 2023 Dec 6.

Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review

Khalifa MKA, Abdel-Sattar SA, Amin OM, Kohaf NA, Zaky HS, Abd El-Fattah MA, Mohammed KHA, Badawi NM, Mansoor I, Eassa HA.

Daru. 2024 Jun;32(1):319-337. doi: 10.1007/s40199-023-00494-8. Epub 2023 Dec 11.

Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review

Vicente-Zurdo D, Rosales-Conrado N, León-González ME.

Talanta. 2024 Mar 1;269:125519. doi: 10.1016/j.talanta.2023.125519. Epub 2023 Dec 7.

Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease

Park J, Simpson C, Patel K.

Ann Pharmacother. 2024 Oct;58(10):1045-1053. doi: 10.1177/10600280231218253. Epub 2023 Dec 14.

Lecanemab: More Questions Than Answers!

Kaur U, Reddy J, Tiwari A, Chakrabarti S, Chakrabarti SS.

Clin Drug Investig. 2024 Jan;44(1):1-10. doi: 10.1007/s40261-023-01331-1. Epub 2023 Dec 14.

Machine learning in Alzheimer's disease drug discovery and target identification

Geng C, Wang Z, Tang Y.

Ageing Res Rev. 2024 Jan;93:102172. doi: 10.1016/j.arr.2023.102172. Epub 2023 Dec 16.

Tau and Alzheimer's disease: Past, present and future

Iqbal K.

Cytoskeleton (Hoboken). 2024 Jan;81(1):116-121. doi: 10.1002/cm.21822. Epub 2023 Dec 21.

Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities

Zang WB, Wei HL, Zhang WW, Ma W, Li J, Yao Y.

Eur J Med Chem. 2024 Feb 5;265:116070. doi: 10.1016/j.ejmech.2023.116070. Epub 2023 Dec 18.

Caspases in Alzheimer's Disease: Mechanism of Activation, Role, and Potential Treatment

Wójcik P, Jastrzębski MK, Zięba A, Matosiuk D, Kaczor AA.

Mol Neurobiol. 2024 Jul;61(7):4834-4853. doi: 10.1007/s12035-023-03847-1. Epub 2023 Dec 23.

Ferroptosis and its modulators: A raising target for cancer and Alzheimer's disease

Singh G, Kesharwani P, Kumar Singh G, Kumar S, Putta A, Modi G.

Bioorg Med Chem. 2024 Jan 15;98:117564. doi: 10.1016/j.bmc.2023.117564. Epub 2023 Dec 20.

Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives

Ayaz M, Mosa OF, Nawaz A, Hamdoon AAE, Elkhalifa MEM, Sadiq A, Ullah F, Ahmed A, Kabra A, Khan H, Murthy HCA.

Phytomedicine. 2024 Feb;124:155272. doi: 10.1016/j.phymed.2023.155272. Epub 2023 Dec 12.

The effects of nitric oxide in Alzheimer's disease

Wang L, Lu D, Wang X, Wang Z, Li W, Chen G.

Med Gas Res. 2024 Dec 1;14(4):186-191. doi: 10.4103/2045-9912.385939. Epub 2023 Sep 17.

Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease

Hasan I, Guo B, Zhang J, Chang C.

Antioxid Redox Signal. 2024 May;40(13-15):863-888. doi: 10.1089/ars.2022.0107. Epub 2023 Feb 23.

People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare

Wahlberg K, Winblad B, Cole A, Herring WL, Ramsberg J, Torontali I, Visser PJ, Wimo A, Wollaert L, Jönsson L.

J Intern Med. 2024 Mar;295(3):281-291. doi: 10.1111/joim.13759. Epub 2023 Dec 14.

2D nanostructures: Potential in diagnosis and treatment of Alzheimer's disease

Tufail S, Sherwani MA, Shamim Z, Abdullah, Goh KW, Alomary MN, Ansari MA, Almosa AA, Ming LC, Abdullah ADI, Khan FB, Menhali AA, Mirza S, Ayoub MA.

Biomed Pharmacother. 2024 Jan;170:116070. doi: 10.1016/j.biopha.2023.116070. Epub 2023 Dec 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias